Lam LL, Pavlakis N, Shitara K, Sjoquist KM, et al. INTEGRATE II: randomised phase III controlled trials of regorafenib containing regimens versus standard of care in refractory Advanced Gastro-Oesophageal Cancer (AGOC): a study by the Australasian Gastro-Intestinal Trials Group (AGITG). BMC Cancer 2023;23:180.
PMID: 36814222